<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00184886</url>
  </required_header>
  <id_info>
    <org_study_id>MTX-Ado</org_study_id>
    <secondary_id>ZonMw Nr. 920-03-249</secondary_id>
    <nct_id>NCT00184886</nct_id>
  </id_info>
  <brief_title>The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans</brief_title>
  <official_title>The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <brief_summary>
    <textblock>
      In this study we aim to determine whether methotrexate influences the metabolism and vascular
      effects of adenosine in humans in vivo. Adenosine is an endogenous purine-nucleoside with
      potent anti-inflammatory effects. Also, adenosine receptor stimulation induces vasodilation,
      ischaemic preconditioning and many other cardiovacular effects. Previous animal studies have
      provided limited evidence that the anti-inflammatory effects of methotrexate are mediated by
      adenosine receptor stimulation. In this study, we aim to determine whether also in humans in
      vivo, methotretate influences endogenous adenosine. Therefore, 10 patients with inflammatory
      arthritis are treated with methotretxae (15 mg/week orally) for 12 weeks. Before and after
      treatment, vasodilation to the infusion of adenosine and dipyridamole into the brachial
      artery is assessed as biomarker for the endogenous adenosine concentration.

      Also, blood is drawn for the determination of CRP, ESR, Adenosine deaminase activity adn
      homocysteine.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2003</start_date>
  <completion_date>January 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vasodilator response to infusion of adenosine and dipyridamole into the brachial artery</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adenosine deaminase activity</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP, BSE, DAS</measure>
  </secondary_outcome>
  <enrollment>10</enrollment>
  <condition>Methotrexate</condition>
  <condition>Vasodilation</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methotrexate 15 mg/week for 12 weeks</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-75 year

          -  polyarthritis

          -  DAS score &gt; 2.5

        Exclusion Criteria:

          -  previous use of MTX

          -  concomitant use of dipyridamole/sulfazalasine

          -  Alcohol &gt; 21 U/week

          -  elevated liver enzymes

          -  pregnancy, breast-feeding, asthma, renal insufficiency, thrombocytopenia,
             leucocytopenia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerard Rongen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Centre</name>
      <address>
        <city>Nijmegen</city>
        <zip>6500HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>February 13, 2006</last_update_submitted>
  <last_update_submitted_qc>February 13, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 14, 2006</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methotrexate</mesh_term>
    <mesh_term>Adenosine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

